Justin Chakma

Justin Chakma

Chief Business OfficeratARS Pharmaceuticals· In the 2025 proxy

Pay in FY2025ARS Pharmaceuticals stock +10.4% the same year

Justin Chakma was paid $2.9M in FY2025 (Dec). ARS Pharmaceuticals stock rose 10.4% that year.

Pay$100 in the stock at the end of FY24 → $110
Pay is from the Summary Compensation Table of each ARS Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ARS PharmaceuticalsPublic company · 1 yr
    • Chief Business Officer2025 – Present · 1 yrStock in role -68%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?